Forget Ozempic: This Obesity-Drug Giant Grabs GLP-1 Gold
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Understanding zero based budgeting versus traditional budgeting can enhance your financial strategy. Explore the key differences today.
19,444 articlesAs GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...
Investors spotted a notable move in the mining space as Coeur Mining stock popped after an earnings beat. This piece ...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
A corporate insider recently sold a sizable block of Symbotic stock. This article breaks down what the sale means, ho...
DraftKings posted strong top-line growth yet issued cautious guidance, sending its stock lower. This analysis breaks ...
The Supreme Court’s Feb. 20 decision voids the tariff program, setting up a possible $175 billion refunds wave that c...
If you’re hunting for a lifelong holding, the dividend track record of Medtronic is hard to ignore. This piece explai...
Aggressive investors chase big upside, and sofi's next breakout: leveraged exposure promises amplified moves. This gu...
Virginia-based City Lending Inc. is winding down operations as regulators tighten oversight and the mortgage market c...
Palantir is navigating a mix of headwinds and catalysts as 2026 unfolds. Here are three grounded predictions palantir...
Meta Platforms signs a multiyear pact with AMD for up to 6 GW of customized GPUs, bolstering a multi-vendor AI chip s...
Dive into Apple Hospitality (APLE) earnings with a practical lens. This guide explains how occupancy, ADR, and cost c...